Development of a CTC-based novel diagnostic technology for unresectable non-small cell lung cancer

被引：0
|
作者：
Onishi, Mami
Morita, Eri
Sakai, Tetsuya
Zenke, Yoshitaka
Yanagida, Masatoshi
Goto, Koichi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3321
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3321
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Impact of Lymphopenia on Treatment Outcomes in Unresectable Non-Small Cell Lung Cancer
    Amorelli, F.
    Martinez, A.
    Liu, F.
    Foro, P.
    Algara, M.
    Sanz, J.
    Membrive, I.
    Taus, A.
    Arriola, E.
    Masfarre, L.
    Navarro, N.
    Rodriguez De Dios, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E2 - E3
  • [32] Optimal Treatment of Unresectable Stage III Non-Small Cell Lung Cancer
    Bradley, Jeffrey D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (11) : 853 - 855
  • [33] Is durvalumab the solution for unresectable stage III non-small cell lung cancer?
    Duma, Narjust
    Mansfield, Aaron S.
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S89 - S93
  • [34] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [35] Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer
    Tsuyoshi Ueno
    Motohiro Yamashita
    Natsumi Yamashita
    Masashi Uomoto
    Osamu Kawamata
    Yoshifumi Sano
    Hidetoshi Inokawa
    Shin Hirayama
    Mikio Okazaki
    Shinichi Toyooka
    General Thoracic and Cardiovascular Surgery, 2022, 70 : 812 - 817
  • [36] Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer
    Ueno, Tsuyoshi
    Yamashita, Motohiro
    Yamashita, Natsumi
    Uomoto, Masashi
    Kawamata, Osamu
    Sano, Yoshifumi
    Inokawa, Hidetoshi
    Hirayama, Shin
    Okazaki, Mikio
    Toyooka, Shinichi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2022, 70 (09) : 812 - 817
  • [37] CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer
    Luo, Yirong
    Zhang, Qichao
    Lv, Bo
    Shang, Yanyan
    Li, Juan
    Yang, Lina
    Yu, Zhiwu
    Luo, Kai
    Deng, Xiaoyan
    Min, Ling
    Zhu, Ting
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37 (01): : 58 - 65
  • [38] Targeted Therapy and Diagnostic Test for Non-Small Cell Lung Cancer
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (23): : 2364 - 2364
  • [39] TAZ is a novel oncogene in non-small cell lung cancer
    Zhou, Z.
    Hao, Y.
    Liu, N.
    Raptis, L.
    Tsao, M-S
    Yang, X.
    ONCOGENE, 2011, 30 (18) : 2181 - 2186
  • [40] TAZ is a novel oncogene in non-small cell lung cancer
    Z Zhou
    Y Hao
    N Liu
    L Raptis
    M-S Tsao
    X Yang
    Oncogene, 2011, 30 : 2181 - 2186
12345